Steroid alternatives for managing eosinophilic lung diseases-Reference-Cited by-同舟云学术

Steroid alternatives for managing eosinophilic lung diseases

Published:2021-10-03 Issue:7-10 Volume:9 Page:205-218
ISSN:2167-8707
Container-title:Expert Opinion on Orphan Drugs
language:en
Short-container-title:Expert Opinion on Orphan Drugs

Author:

Delcros Quentin¹²,Groh Matthieu¹²,Nasser Mouhamad³,Kahn Jean-Emmanuel¹⁴,Cottin Vincent³

Affiliation:

1. National Reference Center for Hypereosinophilic Syndrome (Cereo)

2. Department of Internal Medicine Hôpital Foch, Suresnes, France

3. Department of Respiratory Medicine, National Coordinating Reference Centre for Rare Pulmonary Diseases (Orphalung), Louis Pradel Hospital, Hospices Civils De Lyon, and Claude Bernard University Lyon 1, IVPC, Member of OrphaLung, RespiFIL and ERN-lung, France

4. Department of Internal Medicine, Hôpital Ambroise Paré, Université Paris Saclay, Assistance Publique Hôpitaux De Paris, Boulogne-Billancourt, France

Funder

no funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

https://www.tandfonline.com/doi/pdf/10.1080/21678707.2021.2003777

Reference136 articles.

1. Chronic Eosinophilic Pneumonia

2. Idiopathic Chronic Eosinophilic Pneumonia: A Clinical and Follow-Up Study of 62 Cases

3. Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience;Allergy and Asthma Proceedings;2024-07-01

2. Monoclonal antibodies in idiopathic chronic eosinophilic pneumonia: a scoping review;BMC Pulmonary Medicine;2024-02-08

3. Monoclonal Antibodies in Idiopathic Chronic Eosinophilic Pneumonia: A Scoping Review;2023-06-02

4. Eosinophilic Lung Diseases;Immunology and Allergy Clinics of North America;2023-05

5. Targeting IL-5/5R for the treatment of idiopathic chronic eosinophilic pneumonia;The Journal of Allergy and Clinical Immunology: In Practice;2023-04